Literature DB >> 20018870

Distinct sarcomeric substrates are responsible for protein kinase D-mediated regulation of cardiac myofilament Ca2+ sensitivity and cross-bridge cycling.

Sonya C Bardswell1, Friederike Cuello, Alexandra J Rowland, Sakthivel Sadayappan, Jeffrey Robbins, Mathias Gautel, Jeffery W Walker, Jonathan C Kentish, Metin Avkiran.   

Abstract

Protein kinase D (PKD), a serine/threonine kinase with emerging cardiovascular functions, phosphorylates cardiac troponin I (cTnI) at Ser(22)/Ser(23), reduces myofilament Ca(2+) sensitivity, and accelerates cross-bridge cycle kinetics. Whether PKD regulates cardiac myofilament function entirely through cTnI phosphorylation at Ser(22)/Ser(23) remains to be established. To determine the role of cTnI phosphorylation at Ser(22)/Ser(23) in PKD-mediated regulation of cardiac myofilament function, we used transgenic mice that express cTnI in which Ser(22)/Ser(23) are substituted by nonphosphorylatable Ala (cTnI-Ala(2)). In skinned myocardium from wild-type (WT) mice, PKD increased cTnI phosphorylation at Ser(22)/Ser(23) and decreased the Ca(2+) sensitivity of force. In contrast, PKD had no effect on the Ca(2+) sensitivity of force in myocardium from cTnI-Ala(2) mice, in which Ser(22)/Ser(23) were unavailable for phosphorylation. Surprisingly, PKD accelerated cross-bridge cycle kinetics similarly in myocardium from WT and cTnI-Ala(2) mice. Because cardiac myosin-binding protein C (cMyBP-C) phosphorylation underlies cAMP-dependent protein kinase (PKA)-mediated acceleration of cross-bridge cycle kinetics, we explored whether PKD phosphorylates cMyBP-C at its PKA sites, using recombinant C1C2 fragments with or without site-specific Ser/Ala substitutions. Kinase assays confirmed that PKA phosphorylates Ser(273), Ser(282), and Ser(302), and revealed that PKD phosphorylates only Ser(302). Furthermore, PKD phosphorylated Ser(302) selectively and to a similar extent in native cMyBP-C of skinned myocardium from WT and cTnI-Ala(2) mice, and this phosphorylation occurred throughout the C-zones of sarcomeric A-bands. In conclusion, PKD reduces myofilament Ca(2+) sensitivity through cTnI phosphorylation at Ser(22)/Ser(23) but accelerates cross-bridge cycle kinetics by a distinct mechanism. PKD phosphorylates cMyBP-C at Ser(302), which may mediate the latter effect.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20018870      PMCID: PMC2820795          DOI: 10.1074/jbc.M109.066456

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Power output is increased after phosphorylation of myofibrillar proteins in rat skinned cardiac myocytes.

Authors:  T J Herron; F S Korte; K S McDonald
Journal:  Circ Res       Date:  2001-12-07       Impact factor: 17.367

2.  PKA accelerates rate of force development in murine skinned myocardium expressing alpha- or beta-tropomyosin.

Authors:  J R Patel; D P Fitzsimons; S H Buck; M Muthuchamy; D F Wieczorek; R L Moss
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-06       Impact factor: 4.733

3.  Rate of force generation in muscle: correlation with actomyosin ATPase activity in solution.

Authors:  B Brenner; E Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

4.  Remodelling of cardiomyocyte cytoarchitecture visualized by three-dimensional (3D) confocal microscopy.

Authors:  J M Messerli; M E Eppenberger-Eberhardt; B M Rutishauser; P Schwarb; P von Arx; S Koch-Schneidemann; H M Eppenberger; J C Perriard
Journal:  Histochemistry       Date:  1993-09

5.  Phosphorylation of troponin I controls cardiac twitch dynamics: evidence from phosphorylation site mutants expressed on a troponin I-null background in mice.

Authors:  YeQing Pi; Kara R Kemnitz; Dahua Zhang; Evangelia G Kranias; Jeffery W Walker
Journal:  Circ Res       Date:  2002-04-05       Impact factor: 17.367

6.  Requirement of protein kinase D1 for pathological cardiac remodeling.

Authors:  Jens Fielitz; Mi-Sung Kim; John M Shelton; Xiaoxia Qi; Joseph A Hill; James A Richardson; Rhonda Bassel-Duby; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-14       Impact factor: 11.205

7.  Protein kinase C and A sites on troponin I regulate myofilament Ca2+ sensitivity and ATPase activity in the mouse myocardium.

Authors:  YeQing Pi; Dahua Zhang; Kara R Kemnitz; Hao Wang; Jeffery W Walker
Journal:  J Physiol       Date:  2003-08-15       Impact factor: 5.182

8.  Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5.

Authors:  Rick B Vega; Brooke C Harrison; Eric Meadows; Charles R Roberts; Philip J Papst; Eric N Olson; Timothy A McKinsey
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

9.  Beta-adrenergic receptor stimulation increases unloaded shortening velocity of skinned single ventricular myocytes from rats.

Authors:  K T Strang; N K Sweitzer; M L Greaser; R L Moss
Journal:  Circ Res       Date:  1994-03       Impact factor: 17.367

Review 10.  Cardiac myosin binding protein C: its role in physiology and disease.

Authors:  Emily Flashman; Charles Redwood; Johanna Moolman-Smook; Hugh Watkins
Journal:  Circ Res       Date:  2004-05-28       Impact factor: 17.367

View more
  70 in total

1.  Adrenergic stress reveals septal hypertrophy and proteasome impairment in heterozygous Mybpc3-targeted knock-in mice.

Authors:  Saskia Schlossarek; Friederike Schuermann; Birgit Geertz; Giulia Mearini; Thomas Eschenhagen; Lucie Carrier
Journal:  J Muscle Res Cell Motil       Date:  2011-11-11       Impact factor: 2.698

2.  β-adrenergic effects on cardiac myofilaments and contraction in an integrated rabbit ventricular myocyte model.

Authors:  Jorge A Negroni; Stefano Morotti; Elena C Lascano; Aldrin V Gomes; Eleonora Grandi; José L Puglisi; Donald M Bers
Journal:  J Mol Cell Cardiol       Date:  2015-02-25       Impact factor: 5.000

3.  Increase in cardiac myosin binding protein-C plasma levels is a sensitive and cardiac-specific biomarker of myocardial infarction.

Authors:  Suresh Govindan; Diederik Wd Kuster; Brian Lin; Daniel J Kahn; Walter P Jeske; Jeanine M Walenga; Fred Leya; Debra Hoppensteadt; Jawed Fareed; Sakthivel Sadayappan
Journal:  Am J Cardiovasc Dis       Date:  2013-06-10

4.  Novel function of cardiac protein kinase D1 as a dynamic regulator of Ca2+ sensitivity of contraction.

Authors:  Mariah H Goodall; Robert D Wardlow; Rebecca R Goldblum; Andrew Ziman; W Jonathan Lederer; William Randall; Terry B Rogers
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

5.  The contribution of cardiac myosin binding protein-c Ser282 phosphorylation to the rate of force generation and in vivo cardiac contractility.

Authors:  Kenneth S Gresham; Ranganath Mamidi; Julian E Stelzer
Journal:  J Physiol       Date:  2014-06-20       Impact factor: 5.182

6.  Biochemical and myofilament responses of the right ventricle to severe pulmonary hypertension.

Authors:  Lori A Walker; John S Walker; Amelia Glazier; Dale R Brown; Kurt R Stenmark; Peter M Buttrick
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-05-27       Impact factor: 4.733

Review 7.  Integration of troponin I phosphorylation with cardiac regulatory networks.

Authors:  R John Solaro; Marcus Henze; Tomoyoshi Kobayashi
Journal:  Circ Res       Date:  2013-01-18       Impact factor: 17.367

Review 8.  Oxidative stress and sarcomeric proteins.

Authors:  Susan F Steinberg
Journal:  Circ Res       Date:  2013-01-18       Impact factor: 17.367

9.  Calcium sensitivity, force frequency relationship and cardiac troponin I: critical role of PKA and PKC phosphorylation sites.

Authors:  Genaro A Ramirez-Correa; Sonia Cortassa; Brian Stanley; Wei Dong Gao; Anne M Murphy
Journal:  J Mol Cell Cardiol       Date:  2010-01-18       Impact factor: 5.000

10.  Sex dimorphisms of crossbridge cycling kinetics in transgenic hypertrophic cardiomyopathy mice.

Authors:  Camille L Birch; Samantha M Behunin; Marissa A Lopez-Pier; Christiane Danilo; Yulia Lipovka; Chandra Saripalli; Henk Granzier; John P Konhilas
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-06       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.